Book alleging breaches in Indian pharma industry sparks debate

In a picture taken on Jan 17, 2007, a scientist performs chemical tests at a research and development center at Ranbaxy Laboratories in Gurgaon, India.
In a picture taken on Jan 17, 2007, a scientist performs chemical tests at a research and development center at Ranbaxy Laboratories in Gurgaon, India.PHOTO: BLOOMBERG

US investigative journalist's accounts call into question credibility of 'pharmacy of the world'

Seen as a source of affordable and quality generic medicine for the world, India's pharmaceutical industry has found its credibility questioned by a new book alleging widespread violation of established manufacturing norms by its companies, leading to the production of medicines that potentially risk patients' lives.

Bottle Of Lies - Ranbaxy And The Dark Side Of Indian Pharma, by American investigative journalist Katherine Eban, lays bare instances of cooked-up and plagiarised data, the presence of impurities and foreign particles, and unsanitary manufacturing conditions, among other egregious violations.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on August 20, 2019, with the headline 'Book alleging breaches in Indian pharma industry sparks debate'. Print Edition | Subscribe